| 1 |
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial
Stephen R.D. Johnston et al. · Journal of Clinical Oncology
Open access |
6 Dec 2018 |
239 |
| 2 |
MMAE Delivery Using the Bicycle Toxin Conjugate BT5528
Gavin S. Bennett, Amy N. Brown, Gemma Mudd et al. · Molecular Cancer Therapeutics
|
12 May 2020 |
102 |
| 3 |
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
Michael Rigby, Gavin S. Bennett, Liuhong Chen et al. · Molecular Cancer Therapeutics
Open access |
16 Sep 2022 |
80 |
| 4 |
Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases
Vanessa Baeriswyl, Helen Rapley, Lisa Pollaro et al. · ChemMedChem
Open access |
11 Apr 2012 |
73 |
| 5 |
Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors
Matthias Eder, Silvia Pavan, Ulrike Bauder‐Wüst et al. · Cancer Research
|
3 Jan 2019 |
69 |
| 6 |
Antimicrobial and Cell-Penetrating Peptides: Understanding Penetration for the Design of Novel Conjugate Antibiotics
Andreas Hadjicharalambous, Nikolaos Bournakas, Hector Newman et al. · Antibiotics
Open access |
16 Nov 2022 |
62 |
| 7 |
Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema
Daniel P. Teufel, Gavin S. Bennett, Helen Harrison et al. · Journal of Medicinal Chemistry
Open access |
8 Mar 2018 |
45 |
| 8 |
BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) induces tumor localized CD137 agonism
Kristen E. Hurov, Johanna Lahdenranta, Punit Upadhyaya et al. · Journal for ImmunoTherapy of Cancer
Open access |
Nov 2021 |
38 |
| 9 |
Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma
Yifei Wang et al. · Molecular Cancer Therapeutics
Open access |
21 Mar 2022 |
34 |
| 10 |
Development of a Lc–Ms/Ms Method for the Quantification of Toxic Payload Dm1 Cleaved from Bt1718 in a Phase I Study
Catherine Gowland, Philip Berry, Julie Errington et al. · Bioanalysis
Open access |
2021 |
34 |
| 11 |
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist
Punit Upadhyaya et al. · Journal for ImmunoTherapy of Cancer
Open access |
2021 |
32 |
| 12 |
Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
Laura M. Spring, Hyo Sook Han, Minetta C. Liu et al. · Nature Cancer
Open access |
4 Jul 2022 |
31 |
| 13 |
Disease-relevant β2-microglobulin variants share a common amyloid fold
Martin Wilkinson, Rodrigo U. Gallardo, Roberto Maya‐Martinez et al. · Nature Communications
Open access |
2 Mar 2023 |
30 |
| 14 |
Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC
Michael L. Cheng, Christie J. Lau, Marina S.D. Milan et al. · JCO Precision Oncology
Open access |
17 Feb 2021 |
29 |
| 15 |
A hospital led promotion campaign aimed to increase bicycle helmet wearing among children aged 11–15 living in West Berkshire 1992–98
Angela J. Lee, Nicholas P. Mann, Rachel Allison Takriti · Injury Prevention
Open access |
Jun 2000 |
29 |
| 16 |
Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide
Mohamed El Fakiri, Anusha R. Regupathy, Lisa Uhlmann et al. · Theranostics
Open access |
2024 |
26 |
| 17 |
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2
Katherine U. Gaynor et al. · Nature Communications
Open access |
16 Jun 2023 |
26 |
| 18 |
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors
Babar Bashir, Judy S. Wang, Gerald Steven Falchook et al. · Journal of Clinical Oncology
Open access |
4 Sep 2024 |
25 |
| 19 |
Conjugation to a transferrin receptor 1-binding Bicycle peptide enhances ASO and siRNA potency in skeletal and cardiac muscles
Michael E. Østergaard et al. · Nucleic Acids Research
Open access |
10 Apr 2025 |
23 |
| 20 |
Application of biomimetic HPLC to estimate lipophilicity, protein and phospholipid binding of potential peptide therapeutics
Klara Livia Valko, Gabriela Ivanova-Berndt, Paul Beswick et al. · ADMET & DMPK
Open access |
7 Jun 2018 |
23 |
| 21 |
Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology
Punit Upadhyaya, Julia Kristensson, Johanna Lahdenranta et al. · Journal of Medicinal Chemistry
Open access |
12 Jul 2022 |
22 |
| 22 |
DirectMX – One-Step Reconstitution of Membrane Proteins From Crude Cell Membranes Into Salipro Nanoparticles
Pilar Lloris-Garcerá, Stefan Klinter, Liuhong Chen et al. · Frontiers in Bioengineering and Biotechnology
Open access |
19 Mar 2020 |
20 |
| 23 |
Novel immunotherapeutics against LGR5 to target multiple cancer types
Hung‐Chang Chen et al. · EMBO Molecular Medicine
Open access |
21 Aug 2024 |
19 |
| 24 |
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation
Capucine Baldini et al. · Journal of Clinical Oncology
Open access |
6 Nov 2025 |
15 |
| 25 |
Gold-Mediated Multiple Cysteine Arylation for the Construction of Highly Constrained Bicycle Peptides
Gemma Mudd, Steven J. Stanway, David R. Witty et al. · Bioconjugate Chemistry
|
27 Jul 2022 |
15 |
| 26 |
A C-terminal cysteine residue is required for peptide-based inhibition of the NGF/TrkA interaction at nM concentrations: implications for peptide-based analgesics
Andrew J. Poole, Laura Frigotto, Matthew Edward Smith et al. · Scientific Reports
Open access |
30 Jan 2019 |
10 |
| 27 |
Exploring force-driven stochastic folding dynamics in mechano-responsive proteins and implications in phenotypic variation
Pritam Saha, Vishavdeep Vashisht, Ojas Singh et al. · Nature Communications
Open access |
25 Jan 2025 |
7 |
| 28 |
652P BT8009 monotherapy in enfortumab vedotin (EV)-naïve patients (pts) with metastatic urothelial carcinoma (mUC): Updated results of Duravelo-1
O. Reig Torras, Laurence Crouzet, Andrea Necchi et al. · Annals of Oncology
Open access |
Sep 2024 |
7 |
| 29 |
599TiP BT8009-100 phase I/II study of the safety, pharmacokinetics, & preliminary clinical activity of BT8009 in patients with Nectin-4 expressing advanced malignancies
Meredith Ann McKean, Johanna C. Bendell, Daniel Peter Petrylak et al. · Annals of Oncology
Open access |
Sep 2020 |
7 |
| 30 |
Disposition of Biologics
Kevin Brady, Rob Webster · Advances in pharmacology
Book chapter |
2012 |
7 |
| 31 |
NLRP3 inflammasome–driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors
Farzaneh‐Sadat Rezazadeh‐Shojaee, Esmaeel Azadian, Min Xian Wong et al. · Science Advances
Open access |
9 Jul 2025 |
6 |
| 32 |
Bioanalysis of the Bicycle®Toxin Conjugate BT5528 and Released Monomethyl Auristatin E via Liquid Chromatography–Tandem Mass Spectrometry
Joseph A. Tweed, Fern Adams-Dam, Jane Allanson et al. · Bioanalysis
|
13 Dec 2023 |
6 |
| 33 |
An Assay for Periplasm Entry Advances the Development of Chimeric Peptide Antibiotics
James Mark Wagstaff, Matthew R. Balmforth, Nick Lewis et al. · ACS Infectious Diseases
|
22 Jul 2020 |
6 |
| 34 |
Bicycle helmets: their role in injury prevention
Nicholas P. Mann, A.J. Lee · Current Paediatrics
|
Sep 1999 |
6 |
| 35 |
2025 White Paper on Recent Issues in Bioanalysis: What is the Future of Bioanalytical LIMS? AI/ML Integration in Bioanalysis; Tear Sample Collection; Radiolabeled Mass Balance Studies; Chiral Assays; Bioanalysis of Antibody-Oligonucleotide & Bicycle Drug Conjugates ( PART 1A – Recommendations on Mass Spectrometry Assays, Chromatography, Sample Preparation and Regulated Bioanalysis Sampling, Valida
John Wojcik et al. · Bioanalysis
Open access |
17 Dec 2025 |
5 |
| 36 |
647P EphA2-targeting bicycle toxin conjugate (BTC) BT5528 in patients (pts) with advanced solid tumors: A phase I/II study
Emily Fontana, J.S. Wang, Meredith Ann McKean et al. · Annals of Oncology
Open access |
Sep 2024 |
5 |
| 37 |
Radial Stiffness and Damping of Mountain Bike Tires Subject to Impact Determined Using the Coefficient of Restitution
James Sadauckas, Noah Schoeneck, Mark L. Nagurka · The Evolving Scholar
Open access |
2023 |
5 |
| 38 |
Cycle helmets
A J Lee · Archives of Disease in Childhood
Open access |
23 May 2003 |
5 |
| 39 |
96P: Enhanced anti-tumor activity of zelenectide pevedotin in patients (pts) with non-small cell lung cancer (NSCLC) with NECTIN4 gene amplification (amp)
Loïc Verlingue, N. Klümper, M. Eckstein et al. · Journal of Thoracic Oncology
Open access |
Mar 2025 |
4 |
| 40 |
654P Peripheral neuropathy (PN) following treatment (tx) with bicycle toxin conjugates (BTCs) BT8009 or BT5528 monotherapy in patients (pts) with advanced solid tumors
Bernard Doger de Spéville, Meredith Ann McKean, C. Baldini et al. · Annals of Oncology
Open access |
Sep 2024 |
4 |
| 41 |
650P Initial results from a phase I/II study of BT7480, a novel nectin-4/CD137 bicycle tumor-targeted immune cell agonist, in patients (pts) with advanced solid tumors
Kyriakos P. Papadopoulos, Afshin Dowlati, Juanita Suzanne Lopez et al. · Annals of Oncology
Open access |
Sep 2024 |
4 |
| 42 |
Sarcopenia in colorectal cancer is related to socio-economic deprivation and Body Mass Index alone misrepresents underlying muscle loss in the deprived
Edward Tobias Pring, Laura E. Gould, George Malietzis et al. · Clinical Nutrition ESPEN
|
10 Jun 2024 |
3 |
| 43 |
Identification and Modeling of a Mountain Bike Front Suspension Subsystem Equipped with a Telescopic Fork and Tire Damping
Noah Schoeneck, James Sadauckas, Mark L. Nagurka
Conference paperOpen access |
25 Sep 2023 |
3 |
| 44 |
Nondegenerate Saturation Mutagenesis: Library Construction and Analysis via MAX and ProxiMAX Randomization
Anupama Chembath, Ben P. G. Wagstaffe, Ashraf Mohammed et al. · Methods in molecular biology
Book chapter |
2022 |
3 |
| 45 |
USING A RIDE TO WORK DAY EVENT TO PROMOTE TRAVEL BEHAVIOUR CHANGE
Geoff Rose, Heidi Marfurt, Phil Harbutt
|
2003 |
3 |
| 46 |
Small siphophage binding to an open state of the LptDE outer membrane lipopolysaccharide translocon
Emily Dunbar, Robert L. Clark, Arnaud Baslé et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
7 Jul 2025 |
2 |
| 47 |
A phase 2/3 study of bicycle toxin conjugate zelenectide pevedotin (BT8009) targeting Nectin-4 in patients with locally advanced or metastatic urothelial cancer (la/mUC) (Duravelo-2).
Yohann Loriot, Arlene Odelia Siefker-Radtke, Terence W. Friedlander et al. · Journal of Clinical Oncology
|
10 Feb 2025 |
2 |
| 48 |
The validation and clinical bioanalysis of the Bicycle® Toxin Conjugate zelenectide pevedotin in human plasma
Joseph A. Tweed, Fern Adams-Dam, Justin Bader et al. · Bioanalysis
Open access |
19 Jan 2025 |
2 |
| 49 |
Gluebodies improve crystal reliability and diversity through transferable nanobody mutations that introduce constitutive close contacts
Mingda Ye, Mpho Makola, Joseph A. Newman et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
26 Jul 2022 |
2 |
| 50 |
Bike Sharing System in Shanghai:Planning & Practice
Ming Shou Zhong · Urban Transport of China
|
2009 |
2 |